According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are C$0.08 Million. In 2023 the company made an earning of -C$74.88 Million a decrease over its 2022 earnings that were of -C$49.19 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -C$60.75 Million | -18.88% |
2023 | -C$74.88 Million | 52.24% |
2022 | -C$49.19 Million | 36.61% |
2021 | -C$36.01 Million | 11.48% |
2020 | -C$32.3 Million | 1.46% |
2019 | -C$31.84 Million | -7.37% |
2018 | -C$34.37 Million | -11.46% |
2017 | -C$38.82 Million | 10.67% |
2016 | -C$35.07 Million | 15.7% |
2015 | -C$30.32 Million | -14.86% |
2014 | -C$35.61 Million | 129.19% |
2013 | -C$15.54 Million | -8.55% |
2012 | -C$16.99 Million | |
2010 | C$0.01 M | -152.15% |
2009 | -C$0.03 Million | -39.8% |
2008 | -C$0.04 Million | 120.29% |
2007 | -C$0.02 Million |